Maternal Substance Use During Pregnancy and Congenital Syphilis Among Hospitalized Neonates
OBJECTIVES: US congenital syphilis (CS) cases have increased 10-fold in the past decade, exceeding 3700 cases in 2022. This study evaluated the association between maternal substance use during pregnancy and CS among hospitalized neonates by region and year. METHODS: codes and categorized maternal substance use as no substance use, single substance use, or polysubstance use. Using survey-weighted multivariable logistic regression, we tested effect modification by region and year. RESULTS: Among 4 531 346 hospitalized neonates, 217 220 (weighted prevalence = 2.5%) had maternal substance use during pregnancy. CS prevalence among substance-exposed neonates increased 467% from 2.5 to 14.5 per 1000 neonates between 2016 and 2022, compared with 0.2 to 0.8 per 1000 neonates among unexposed neonates. After adjusting for demographic charateristics, health insurance status, median household income, housing insecurity, year, and region, single substance use and polysubstance use were associated with higher odds of CS (single substance use: adjusted odds ratio [AOR] = 9.68; 95% CI, 8.88-10.55; and polysubstance use: AOR = 17.18; 95% CI, 15.21-19.40). We observed a significant effect modification: the association was much stronger in the West region of the United States (interaction OR = 4.80; 95% CI, 3.10-7.44) than in the Northeast, and the polysubstance use association was significantly elevated in 2022 relative to 2016 (interaction OR = 3.10; 95% CI, 1.81-5.30). CONCLUSIONS: Maternal substance use was strongly associated with CS. These findings underscore the need to address structural barriers to prenatal care through the expansion and integration of syphilis screening within substance use treatment and harm-reduction contexts, especially in regions with a high burden of CS.
Authors
- Su Jin Joo (ORCID: https://orcid.org/0000-0003-0798-6872)
- Sarah Leir
- Hebatalla Shamseldin (ORCID: https://orcid.org/0009-0000-2659-5098)
- Amy Koid (ORCID: https://orcid.org/0009-0008-6771-8697)
Institutions
- Harvard University (US)
- University of Ottawa (CA)
- University of California, San Francisco (US)
- University of California System (US)
- Mount St. Mary's University (US)
- Global Brain Health Institute (US)
- Mount St. Mary's University (US)
Publication Details
- Journal
- Public Health Reports
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1177/00333549261497292
- Primary Topic
- Syphilis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00